UNSPSC 51111775: Bizelesin

This classification denotes an antineoplastic alkylating agent with the molecular formula C43H36Cl2N8O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier L0O9OBI87E, chemically known as 1,3-bis(2-(((s)-1-(chloromethyl)-1,6-dihydro-5-hydroxy-8-methylbenzo(1,2-b:4,3-b)dipyrrol-3(2h)-yl)carbonyl)indol-5-yl)urea but more generally known as bizelesin, which bears US NIH Compound Identifier 60794. European Medicines Agency schedules Bizelesin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05863MIG.

UNSPSC 51111775 Bizelesin is a Commodity code for pharmaceutical products; state and local governments soliciting under it are purchasing specific medications and drug-related supplies to support public health and emergency response initiatives. The recent opportunities show procurement of both prescription antibiotics (Doxycycline Hyclate, Ciprofloxacin Hydrochloride) for disease preparedness stockpiling and opioid-reversal agents (Naloxone) paired with drug deactivation systems for community health and harm-reduction programs. Issuing bodies include state departments of public health and county health authorities; the Illinois Department of Public Health and Seminole County, Florida both appear in recent awards. Purchases are structured as fixed-price contracts with multi-year terms and renewal options, and vendors must meet standard workplace compliance requirements including drug-free workplace certification and E-Verify authorization.

Recent activity spans at least two states. The Illinois Department of Public Health awarded a $2,999,999.11 piggyback contract through the MMCAP Infuse consortium to Chartwell Rx LLC in August 2026 via IFB for antibiotic tablets with a 12-month initial term and two renewal years. Seminole County, Florida released an IFB in June 2026 for annual procurement of 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems with quarterly deliveries to the Seminole County Community Health Building; the IFB closing date was July 26, 2023, and bidders were required to include all shipping and delivery costs in pricing and comply with potential FEMA audit and federal environmental regulations if funding flows through that source.